Niagen Bioscience, Inc.
NAGE · Medicinal Chemicals & Botanical Products · 79.6M shares · +6%/yr ↑ shares · EDGAR filings ↗
Reference price $6.81 · est. market cap ~$542M — last insider purchase, 2025-11-14 (estimated from the dated SEC Form 4 price × shares outstanding — not a live quote)
Grade
B72NAD/supplements company (Tru Niagen) — profitable, growing, with strong asset returns.
Strengths
- Profitable, strong returns — operating margin 13% (94th), ROA 16% (88th)
- Strong liquidity — current ratio 4.9 (92nd)
- Differentiated NAD-precursor IP — per 10-K
Risks
- Supplements/regulatory and competition risk — per 10-K
- Customer/channel concentration — per 10-K
- Thin OCF margin — 10%
Notable findings
- Fund exitedNotable fund(s) exited this quarter: VANGUARD GROUP INC
- Notable holderHeld by 5 notable fund(s): RENAISSANCE TECHNOLOGIES LLC, GOLDMAN SACHS GROUP INC, STATE STREET CORP +2 more (as of 2026-03-31)
Quarterly revenue
Last 4 quarters · from SEC filings.
Key metrics
Gross margin
64.3%
Operating margin
12.6%
Net margin
13.4%
Return on equity
22.7%
Return on assets
16.3%
Revenue growth (QoQ)
-7.0%
Net-income growth
103.3%
Current ratio
4.9×
Tangible book value
$71M
Stock comp / revenue
4.7%
Insider transactions · last 18 months
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2026-04-24 | Fried Robert N | Option exercise | 20K | $2.61 |
| 2025-11-14 | Pamir Ozan | Buy | 4.5K | $6.81 |
| 2025-11-14 | Pamir Ozan | Buy | 2.2K | $6.85 |
| 2025-04-09 | Fried Robert N | Option exercise | 67K | $3.30 |
| 2025-03-07 | Lopez Carlos Luis | Buy | 273 | $7.86 |
All non-derivative Form 4 activity (SEC), newest first.
Notable events (8-K)
| Date | Items | |
|---|---|---|
| 2026-05-06 | ResultsReg FDExhibits | filing ↗ |
| 2026-03-19 | OtherExhibits | filing ↗ |
| 2026-03-04 | ResultsReg FDExhibits | filing ↗ |
| 2026-02-26 | Reg FDOtherExhibits | filing ↗ |
| 2025-12-22 | Material agreementReg FDExhibits | filing ↗ |
| 2025-11-06 | OtherExhibits | filing ↗ |
| 2025-11-04 | ResultsReg FDExhibits | filing ↗ |
| 2025-10-06 | Reg FDExhibits | filing ↗ |
Recent filings
| Form | Filed | Period | Accession |
|---|---|---|---|
| 10-Q | 2026-05-06 | 2026-03-31 | 0001386570-26-000030 ↗ |
| 8-K | 2026-05-06 | 2026-05-06 | 0001386570-26-000031 ↗ |
| 8-K | 2026-03-19 | 2026-03-19 | 0001386570-26-000017 ↗ |
| 8-K | 2026-03-04 | 2026-03-04 | 0001386570-26-000014 ↗ |
| 10-K | 2026-03-04 | 2025-12-31 | 0001386570-26-000013 ↗ |
| 8-K | 2026-02-26 | 2026-02-24 | 0001386570-26-000003 ↗ |
| 8-K | 2025-12-22 | 2025-12-18 | 0001386570-25-000030 ↗ |
| 8-K | 2025-11-06 | 2025-11-06 | 0001386570-25-000025 ↗ |
| 10-Q | 2025-11-04 | 2025-09-30 | 0001386570-25-000020 ↗ |
| 8-K | 2025-11-04 | 2025-11-04 | 0001386570-25-000021 ↗ |
| 8-K | 2025-10-06 | 2025-10-06 | 0001386570-25-000015 ↗ |
| 8-K | 2025-08-06 | 2025-08-06 | 0001386570-25-000011 ↗ |